Navigation Links
MedImmune Expands Scientific and Engineering Leadership
Date:12/20/2007

tion on a global level. Before joining Amgen, Mr. Skibo served in engineering management positions focused on pharmaceuticals and bioscience at Skanska, Inc; Foster Wheeler Corp.; Life Sciences International, Inc.; A.D. Skibo & Associates, Inc.; and Genentech, Inc. Mr. Skibo holds a master of science degree in chemical engineering with a specialty in biomedical engineering and a bachelor of science degree in organic chemistry, both from Massachusetts Institute of Technology.

Management Promotion

As vice president, infectious disease research, Dr. Suzich is responsible for overseeing MedImmune's research in the development of antibodies and antibody-like molecules for the prophylaxis and treatment of infectious disease. Since joining MedImmune in 1988 in the role of scientist, she has held several positions of increasing responsibility, most recently as senior director, infectious disease research. During her tenure with the company she has been involved in many key development programs, including Synagis(R) (palivizumab) and the virus-like particle technology that is the basis of the new human papillomavirus (HPV) vaccines used to prevent cervical cancer. Dr. Suzich holds a doctorate in biochemistry from Purdue University and graduated magna cum laude with a bachelor of science degree in biology from Susquehanna University.

New Cambridge Site Leadership Team

MedImmune also announced today that following the integration of CAT into MedImmune, several personnel were appointed to the new Cambridge site leadership team under the guidance of John Stageman, Ph.D., vice president and interim site head.

Dr. Stageman has nearly 30 years of experience in R&D management throughout AZ and its predecessor companies, having pioneered large-scale biotechnology process development and scale-up at the start of his career. He entered the pharmaceutical business in 1993 rising through a number of senior roles in both drug discovery and development pr
'/>"/>

SOURCE MedImmune
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
4. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
7. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
8. Rohm and Haas Expands in India
9. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
10. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
11. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... On August 30, 2014, Harper’s Bazaar Magazine ... Should Wash Your Face .” According to the ... breathes air considered polluted by the World Health Organization. ... skin’s pores destroying its natural oils. These oils act ... may cause cell damage, redness, aging skin , ...
(Date:9/2/2014)... with early-stage breast cancer in California, the percentage undergoing ... although this procedure was not associated with a lower ... to a study in the September 3 issue of ... for the removal of one breast was associated with ... examined in the study. , Randomized trials have demonstrated ...
(Date:9/2/2014)... emergency department within a few days of discharge do so ... lost trust in other parts of the health care system, ... in Annals of Emergency Medicine ( "Return Visits ... , "When asked why they did not follow up as ... severe to wait until their scheduled appointment or being instructed ...
(Date:9/2/2014)... Operators in the Community Services industry ... care and counsel for those in need. In 2014-15, ... derive $39.4 billion in revenue, which includes a combination ... five years through 2014-15, the subdivision is forecast to ... of 4.1% in 2014-15. , As the population ages ...
(Date:9/2/2014)... Steven Reinberg ... News) -- Stimulant medications -- such as Adderall, Ritalin ... in children, won,t stunt their growth, a new study ... height as adults," said study researcher Dr. Slavica Katusic, ... in Rochester, Minn. Katusic noted that results of ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 2Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 3
... with higher blood levels of chemicals used in the ... likely to have elevated total and LDL cholesterol levels, ... Archives of Pediatrics & Adolescent Medicine , one ... the man-made compounds known as perfluoroalkyl acidsincluding perfluorooctanoic acid ...
... one-fifth of fathers in the United Kingdom appear to experience ... year of age, with the highest rates in the first ... that will appear in the November print issue of ... JAMA/Archives journals. "Depression in parents is associated with adverse ...
... MONDAY, Sept. 6 (HealthDay News) -- Money can help buy ... a year, new research shows. While happiness increases along ... earning more money has no effect on day-to-day contentment, according ... give up trying to get that promotion. While making more ...
... , FRIDAY, Sept. 3 (HealthDay News) -- Feeding obese mice ... a new study finds. Fish oil supplements that contain ... most popular dietary supplements in the United States. While omega-3 ... they work hasn,t been well understood, said study co-author Saswata ...
... CAMBRIDGE, Mass. - Phosphorus, a mineral element found in ... pesticides, detergents and other industrial and household chemicals. Once ... products is hazardous and expensive, and chemists have been ... chemistry professor Christopher Cummins and one of his graduate ...
... Amanda Gardner HealthDay Reporter , FRIDAY, Sept. 3 ... in flophouses, theaters and high-end offices, bedbugs are popping up ... more places than just your bed. According ... 95 percent of U.S. pest management companies surveyed said they ...
Cached Medicine News:Health News:Compounds in non-stick cookware may be associated with elevated cholesterol in children and teens 2Health News:Parents at highest risk for depression in the first year after child's birth 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 2Health News:After $75,000, Money Can't Buy Day-to-Day Happiness 3Health News: Mouse Study May Help Explain Fish Oil's Benefits 2Health News: Mouse Study May Help Explain Fish Oil's Benefits 3Health News:MIT moves toward greener chemistry 2Health News:MIT moves toward greener chemistry 3Health News:Bedbug Nation: Critters Make a Comeback 2Health News:Bedbug Nation: Critters Make a Comeback 3Health News:Bedbug Nation: Critters Make a Comeback 4
(Date:9/2/2014)... , España, September 2, 2014 ... global de fibrilación atrial muestran agentes antitrombóticos no ... -- Las presentaciones de GARFIELD-AF ... sobre el tratamiento y los resultados de pacientes ... clínica diaria --    Los datos ...
(Date:9/2/2014)... -- According to the new market research ... by Material (Metal, Glass, Plastic), by Application [GC, LC ... published by MarketsandMarkets, the Chiral Chromatography Columns Market was ... grow at a CAGR of 5.2% from 2013 to ... 90 market data tables and 15 figures spread through ...
(Date:9/2/2014)... 2014 Particle Sciences, the leading CDMO for ... development and manufacturing capabilities with the addition of a ... Particle Sciences, Associate Director Clinical Production, "The company has ... square footage, equipment and staff across the board, all ... has over 6000ft 2 of operating cleanroom and ...
Breaking Medicine Technology:Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2
... Sept. 2 NewCardio (OTC Bulletin Board: NWCI ... Renz, Jr., NewCardio,s President and CEO, purchased 128,000 shares during ... weeks following the Company,s filing of its SEC Form 10-Q ... 2010. "As discussed on our August 12, ...
... SKILLMAN, N.J., Sept. 2 ConvaTec, a world-leading developer ... hospital care, announced today the introduction of a new, ... with Strengthening Fibers, now available in the U.S. and ... highly exuding chronic and acute wounds. The new dressing, ...
Cached Medicine Technology:NewCardio CEO Increases Equity Position 2NewCardio CEO Increases Equity Position 3NewCardio CEO Increases Equity Position 4ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 2ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 3ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: